Structure (2D) of SU5416, a chemical compound discovered by Sugen Pharmaceuticals and entered into a discontinued clinical trial in man. Redrawn using MDL ISIS/Draw 2.5 from figure published in the 11 April 2005 issue of The Scientist, where it appeared courtesy the Department of Pharmacology, Yale University School of Medicine.
Source: Schlessinger, Joseph (2005). "SU11248: Genesis of a New Cancer Drug". The Scientist 19(7):17-24.
Public domainPublic domainfalsefalse
This image of a simple structural formula is ineligible for copyright and therefore in the public domain, because it consists entirely of information that is common property and contains no original authorship.
ಕಡತದ ಇತಿಹಾಸ
ದಿನ/ಕಾಲ ಒತ್ತಿದರೆ ಆ ಸಮಯದಲ್ಲಿ ಈ ಕಡತದ ವಸ್ತುಸ್ಥಿತಿ ತೋರುತ್ತದೆ.
Structure (2D) of SU5416, a chemical compound discovered by Sugen Pharmaceuticals and entered into a discontinued clinical trial in man. Redrawn using MDL ISIS/Draw 2.5 from figure published in the 11 April 2005 issue of The Scientist, where it appeared c